Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Tapan M. Kadia"'
Autor:
Elias J. Jabbour, Koji Sasaki, Fadi G. Haddad, Ghayas C. Issa, Guillermo Garcia‐Manero, Tapan M. Kadia, Nitin Jain, Musa Yilmaz, Courtney D. DiNardo, Keyur P. Patel, Rashmi Kanagal‐Shamanna, Richard Champlin, Issa F. Khouri, Sara Dellasala, Sherry A. Pierce, Hagop Kantarjian
Publikováno v:
American Journal of Hematology. 98:658-665
Autor:
Curtis A. Lachowiez, Patrick K. Reville, Hagop Kantarjian, Elias Jabbour, Gautam Borthakur, Naval Daver, Ghayas Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guilin Tang, Keyur P. Patel, Jeffrey Medeiros, Hussein A. Abbas, Fadi Haddad, Daniel Hammond, Nicholas J. Short, Abhishek Maiti, Musa Yilmaz, Koji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Konopleva, Guillermo Garcia‐Manero, Farhad Ravandi, Tapan M. Kadia, Sanam Loghavi, Courtney D. DiNardo
Publikováno v:
American Journal of Hematology. 97:1443-1452
Autor:
Kunhwa Kim, Marina Konopleva, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Guilin Tang, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Caitlin R. Rausch, Musa Yilmaz, Koji Sasaki, Nicholas J. Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia
Publikováno v:
American Journal of Hematology. 97:885-894
Newly diagnosed acute myeloid leukemia is often deemed a medical emergency, requiring urgent treatment. This is in contradiction with the need for accurate cytogenetic and molecular data, which is not immediately available, to select optimal therapy.
Autor:
Patrick K. Reville, Koji Sasaki, Hagop M. Kantarjian, Naval G. Daver, Musa Yilmaz, Courtney D. Dinardo, Nicholas J. Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S. Mehta, Sherry Pierce, Sergej N. Konoplev, Joseph D. Khoury, Guillermo Garcia‐Manero, Marina Y. Konopleva, Elias Jabbour, Farhad Ravandi, Tapan M. Kadia
Publikováno v:
American Journal of Hematology. 97:329-337
Autor:
Farhad Ravandi, Nitin Jain, Naval Daver, Courtney D. DiNardo, Guillermo Garcia-Manero, Kebede H. Begna, Hagop M. Kantarjian, Guillermo Montalban Bravo, Nicholas J. Short, Ayalew Tefferi, Tapan M. Kadia, Lucia Masarova, Sherry Pierce, Gautam Borthakur, Koji Sasaki, Elias Jabbour, Marina Konopleva
Publikováno v:
American Journal of Hematology. 97:68-78
The progress with intensive chemotherapy and supportive care measures has improved survival in patients with newly diagnosed acute myeloid leukemia (AML). Given the recent development of effective low intensity therapies, an optimal decision on the t
Autor:
Farhad Ravandi, Joseph D. Khoury, Ghayas C. Issa, Elias Jabbour, Steven M. Kornblau, Mehrnoosh Tashakori, Koichi Takahashi, Courtney D. DiNardo, Sanam Loghavi, Veronica A Guerra, Hagop M. Kantarjian, Tapan M. Kadia, Marina Konopleva, Naval Daver, Nicholas J. Short, Yasmin Alwash, Rashmi Kanagal-Shamanna
Publikováno v:
Am J Hematol
TP53 mutations in acute myeloid leukemia (AML) are associated with resistance to standard treatments and dismal outcomes. The incidence and prognostic impact of the emergence of newly detectable TP53 mutations over the course of AML therapy has not b
Autor:
Zeev Estrov, Nitin Jain, Elias Jabbour, Srdan Verstovsek, Guillermo Garcia-Manero, Sherry Pierce, Farhad Ravandi, Uday R. Popat, Marina Konopleva, Xuelin Huang, Naval Daver, Naveen Pemmaraju, Hagop M. Kantarjian, Xuemei Wang, Gautam Borthakur, Caitlin R. Rausch, Alessandra Ferrajoli, Tapan M. Kadia, Jan A. Burger, Rashmi Kanagal-Shamanna, Courtney D. DiNardo
Publikováno v:
American Journal of Hematology. 96:914-924
Background The treatment of older patients with newly diagnosed acute myeloid leukemia (AML) using intensive chemotherapy is associated with treatment intolerance and poor survival. We evaluated two new lower-intensity regimens with clofarabine (n=11
Autor:
Keyur P. Patel, Michael Andreeff, Zhihong Zeng, Naval Daver, Gautam Borthakur, Hsiang Chun Chen, Ru Yiu Wang, Teresa McQueen, Marina Konopleva, Mary A. Kelly, Hagop M. Kantarjian, Jorge E. Cortes, Tapan M. Kadia, Xuelin Huang, Farhad Ravandi
Publikováno v:
American Journal of Hematology. 95:1296-1303
Stroma-leukemia interactions mediated by CXCR4, CD44, VLA4, and their respective ligands contribute to therapy resistance in FLT3-ITD-mutated acute myelogenous leukemia (AML). We conducted a phase 1 study with the combination of sorafenib (a FLT3-ITD
Autor:
Patrick K, Reville, Koji, Sasaki, Hagop M, Kantarjian, Naval G, Daver, Musa, Yilmaz, Courtney D, Dinardo, Nicholas J, Short, Gautam, Borthakur, Naveen, Pemmaraju, Rohtesh S, Mehta, Sherry, Pierce, Sergej N, Konoplev, Joseph D, Khoury, Guillermo, Garcia-Manero, Marina Y, Konopleva, Elias, Jabbour, Farhad, Ravandi, Tapan M, Kadia
Publikováno v:
Am J Hematol
Mutations in in fms-like tyrosine kinase 3 (FLT3) gene are common genomic alterations in acute myeloid leukemia (AML). FLT3 internal tandem duplication mutations (FLT3-ITD) have consistently been shown to be adversely prognostic, particularly those w
Autor:
Tapan M. Kadia, Ayalew Tefferi, Horatiu Olteanu, Courtney D. DiNardo, Elias Jabbour, Ginna L. Granroth, Naseema Gangat, Aref Al-Kali, Mrinal M. Patnaik, Marina Konopleva, Naveen Pemmaraju, James M. Foran
Publikováno v:
American journal of hematology. 97(2)